Literature DB >> 25978962

Separation and peroxisome proliferator-activated receptor-γ agonist activity evaluation of synthetic racemic bavachinin enantiomers.

Guoxin Du1, Li Feng1, Zhuo Yang2, Jiye Shi3, Cheng Huang1, Fujiang Guo1, Bo Li2, Weiliang Zhu4, Yiming Li5.   

Abstract

Bavachinin, isolated from Psoralea corylifolia seeds, has been reported to demonstrate peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist activity. However, isolated bavachinin is actually a mixture of S and R configurations, with an enantiomeric excess value of approximately 24.3%. For further study on the structure-activity relationships of bavachinin, investigating the PPAR-γ agonist activity of the two enantiomers is crucial. Considering the limited availability, racemic bavachinin was prepared in this study using chemical synthesis. The enantiomers of racemic bavachinin were then separated using supercritical fluid chromatography. This concise strategy yielded (S)- and (R)-bavachinin in optical purity as high as ⩾97.5%. The PPAR-γ agonist activity of the two enantiomers was evaluated using a time-resolved fluorescence resonance energy transfer-based competitive binding assay method; IC50 values of (S)- and (R)-bavachinin were 616.7 and 471.2 nM, respectively. The interaction between the compounds and PPAR-γ was further explored using a molecular docking method. This study suggests that (S)- and (R)-bavachinin demonstrate similar PPAR-γ agonist activities.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bavachinin; Binding assay; Molecular docking; PPAR-γ; Supercritical fluid chromatography

Mesh:

Substances:

Year:  2015        PMID: 25978962     DOI: 10.1016/j.bmcl.2015.04.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.940


  7 in total

1.  Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.

Authors:  Xinqiang Li; Han Xing; Zifei Qin; Jing Yang; Peile Wang; Xiaojian Zhang; Zhihong Yao; Xinsheng Yao
Journal:  RSC Adv       Date:  2020-09-23       Impact factor: 4.036

2.  Study on the 2-Phenylchroman-4-One Derivatives and their anti-MERS-CoV Activities.

Authors:  Ji Hye Yoon; Jihye Lee; Jun Young Lee; Young Sup Shin; Dong Eon Kim; Jung Sun Min; Chul Min Park; Jong Hwan Song; Seungtaek Kim; Sunoh Kwon; Min Seong Jang; Hyoung Rae Kim
Journal:  Bull Korean Chem Soc       Date:  2019-07-28

3.  Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes.

Authors:  Hyejin Lee; Hua Li; Minsoo Noh; Jae-Ha Ryu
Journal:  Int J Mol Sci       Date:  2016-04-08       Impact factor: 5.923

4.  Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B.

Authors:  Najla O Zarmouh; Elizabeth A Mazzio; Faisel M Elshami; Samia S Messeha; Suresh V K Eyunni; Karam F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

5.  Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.

Authors:  Atieh Hajirahimkhan; Obinna Mbachu; Charlotte Simmler; Sarah G Ellis; Huali Dong; Dejan Nikolic; David C Lankin; Richard B van Breemen; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  J Nat Prod       Date:  2018-04-11       Impact factor: 4.050

6.  Bavachinin Induces Oxidative Damage in HepaRG Cells through p38/JNK MAPK Pathways.

Authors:  Shan Wang; Min Wang; Min Wang; Yu Tian; Xiao Sun; Guibo Sun; Xiaobo Sun
Journal:  Toxins (Basel)       Date:  2018-04-12       Impact factor: 5.075

Review 7.  Effects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases.

Authors:  Yi-Ting Zhou; Lin Zhu; Yunyun Yuan; Shuang Ling; Jin-Wen Xu
Journal:  Oxid Med Cell Longev       Date:  2020-06-17       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.